GCI Health, a global health impact agency, announced the appointment of Ravi Moorthy as Managing Director, Global Corporate Lead.
Moorthy brings extensive experience in corporate communications from both in-house and agency roles across the U.S., Europe and Middle East, spanning the healthcare, technology, financial services and professional services sectors.
Moorthy joins GCI Health from Scorpion Therapeutics, an AI-powered biotechnology company, where he served as Vice President, Head of Communications. Prior to that, Moorthy was Managing Director, Corporate and Public Affairs, at Edelman, where he grew the Bay Area team and served as senior lead for several multinational companies. He also worked at Mubadala, a sovereign investment company responsible for building a modern healthcare infrastructure in the United Arab Emirates (UAE), where he built and protected the company’s reputation through holistic communications strategies in both the UAE and international markets.
He will be responsible for advancing the agency’s corporate communications capabilities by further integrating them with GCI Health’s best-in-class creative, data, digital, media, policy and strategic offerings.
Kristin Cahill, Global CEO, GCI Health, said, “There has never been a more pivotal time for healthcare organizations to elevate their corporate reputation, shape executive visibility and engage employees in meaningful ways. Ravi brings global and cross-sector experience in shaping corporate communications that our clients need to create impact in today’s complex environment.”
Ravi Moorthy said, “The opportunity for strategic communications counselors to protect and promote their client’s corporate reputations and clearly demonstrate value to all stakeholders has never been greater. It’s an exciting time to be working in the ever-broadening healthcare ecosystem, and there’s no better place to do that than GCI Health, with its strong brand, impressive client roster and deep professional expertise. I’m keen to partner with the team and expand on the excellent work already underway and continue building this iconic healthcare agency.”
